Decline in Cash and Cash Equivalents
First written in FY2018-Q2. 10 of 28 entries say "Worsened", first in FY2020-Q2. Latest entry: FY2026.
Pharma Foods International moved to the "Worse" side of this theme in 2025, 1 year after the typical company in this theme (2024).
14 other companies' latest entry also says "Worsened".
- FY2026WorsenedAnnual report
「Cash and cash equivalents at the end of the current consolidated fiscal year decreased by ¥1,365 million from the end of the previous consolidated fiscal year to ¥7,691 million, down 15.1% year on year.」
Cash and cash equivalents decreased from ¥9,057 million at the end of the previous fiscal year to ¥7,691 million, while cash flows from operating activities and investing activities were both outflows. - FY2025-H1WorsenedAnnual report
「Cash and cash equivalents at the end of the interim consolidated fiscal period decreased by ¥4,559 million from the end of the previous consolidated fiscal year to ¥11,006 million, down 29.3% year on year.」
Cash and cash equivalents decreased by ¥4,559 million from ¥15,566 million at the end of the previous consolidated fiscal year to ¥11,006 million. - FY2024WorsenedAnnual report
「Cash and cash equivalents at the end of the current consolidated fiscal year decreased by ¥739 million from the end of the previous consolidated fiscal year to ¥15,566 million, down 4.5% year on year.」
Cash and cash equivalents decreased by ¥739 million from the end of the previous fiscal year to ¥15,566 million. - FY2024-Q2AdvancedAnnual report
「Cash and cash equivalents at the end of the second quarter of the current consolidated fiscal year increased by ¥694 million from the end of the previous consolidated fiscal year to ¥17,001 million, up 4.3% year on year.」
Cash and cash equivalents increased by ¥694 million from the end of the previous consolidated fiscal year to ¥17,001 million. - FY2024-Q1AdvancedAnnual report
「Total assets at the end of the first quarter of the current consolidated fiscal year increased by ¥1,448 million from the end of the previous consolidated fiscal year to ¥37,680 million, up 4.0% year on year. This was mainly due to a ¥1,123 million increase in cash and deposits and a ¥244 million increase in deferred tax assets.」
Cash and deposits increased by ¥1,123 million from the end of the previous consolidated fiscal year to ¥17,429 million. - FY2023AdvancedAnnual report
「Cash and cash equivalents at the end of the current consolidated fiscal year increased by ¥7,460 million from the end of the previous consolidated fiscal year to ¥16,306 million, up 84.4% year on year.」
Cash and cash equivalents increased from ¥8,845 million at the end of the previous fiscal year to ¥16,306 million, while cash flow from operating activities was an inflow of ¥6,125 million. - FY2023-Q2AdvancedAnnual report
「Cash and cash equivalents at the end of the second quarter of the current consolidated fiscal year increased by ¥4,130 million from the end of the previous consolidated fiscal year to ¥12,976 million, up 46.7% year on year.」
Cash and cash equivalents increased by ¥4,130 million from the end of the previous fiscal year to ¥12,976 million. - FY2023-Q1Cash balance turned from a decrease to an increaseAnnual report
「Total assets at the end of the first quarter of the current consolidated fiscal year increased by ¥1,543 million from the end of the previous consolidated fiscal year to ¥32,702 million, up 5.0% year on year. This was mainly due to a ¥3,199 million increase in cash and deposits and a ¥1,253 million decrease in notes and accounts receivable resulting from the collection of trade receivables in the business-to-consumer business, among other factors.」
Following a decrease at the end of the previous fiscal year, cash and deposits increased by ¥3,199 million, bringing the balance to ¥12,045 million. - FY2022WorsenedAnnual report
「Cash and cash equivalents at the end of the current consolidated fiscal year decreased by ¥948 million from the end of the previous consolidated fiscal year to ¥8,845 million, down 9.7% year on year.」
Cash and cash equivalents decreased by ¥948 million from the end of the previous fiscal year, while cash flow from operating activities was an outflow of ¥6,065 million. - FY2022-Q3WorsenedAnnual report
「The balance of cash and cash equivalents at the end of the third quarter of the current consolidated fiscal year was ¥9,545 million, and we believe that the necessary funds have been secured.」
Cash and cash equivalents decreased from ¥9,794 million at the end of the previous fiscal year to ¥9,545 million. The disclosure also states that the necessary funds have been secured. - FY2022-Q2WorsenedAnnual report
「Cash and cash equivalents at the end of the second quarter of the current consolidated fiscal year decreased by ¥1,895 million from the end of the previous consolidated fiscal year to ¥7,899 million.」
Cash and cash equivalents decreased by ¥1,895 million from ¥9,794 million at the end of the previous fiscal year to ¥7,899 million. - FY2022-Q1AdvancedAnnual report
「The balance of cash and cash equivalents at the end of the first quarter of the current consolidated fiscal year was ¥11,190 million, and we believe that the necessary funds have been secured.」
Cash and cash equivalents increased by ¥1,396 million from ¥9,794 million at the end of the previous fiscal year to ¥11,190 million. - FY2021AdvancedAnnual report
「Cash and cash equivalents at the end of the current consolidated fiscal year increased by ¥6,511 million from the end of the previous consolidated fiscal year to ¥9,794 million, due to profit before income taxes of ¥5,765 million (¥848 million in the same period of the previous year) and increases in trade receivables and inventories, among other factors. This represented a 198.4% year-on-year increase.」
Cash and cash equivalents increased by ¥6,511 million from the end of the previous fiscal year to ¥9,794 million. - FY2021-Q3AdvancedAnnual report
「This was mainly due to a ¥4,346 million increase in cash and deposits, a ¥1,935 million increase in notes and accounts receivable resulting from expanded sales in the mail-order business, among other factors, and a ¥939 million increase in merchandise and finished goods.」
Cash and deposits increased by ¥4,346 million from the end of the previous consolidated fiscal year, bringing the balance at the end of April 2021 to ¥7,628 million. - FY2021-Q2AdvancedAnnual report
「Cash and cash equivalents at the end of the second quarter of the current consolidated fiscal year increased by ¥2,431 million from the end of the previous consolidated fiscal year to ¥5,714 million.」
Cash continued to increase from the end of the previous consolidated fiscal year, and cash and cash equivalents reached ¥5,714 million. - FY2021-Q1Cash balance turned from a decrease to an increaseAnnual report
「This was mainly due to a ¥2,162 million increase in cash and deposits and a ¥1,978 million increase in notes and accounts receivable resulting from expanded sales in the mail-order business, among other factors.」
Cash and deposits increased by ¥2,162 million from the end of the previous consolidated fiscal year, bringing the balance to ¥5,444 million. The trend has shifted from a decline through the previous quarter to an increase. - FY2020-Q3MitigatedAnnual report
「Total assets at the end of the third quarter of the current consolidated fiscal year increased by ¥601 million from the end of the previous consolidated fiscal year to ¥9,333 million. This was mainly due to a ¥1,662 million decrease in cash and deposits resulting from increased advertising investment,」
Cash and deposits decreased by ¥1,662 million from the end of the previous consolidated fiscal year, but the decline was smaller than the ¥2,046 million decrease recorded at the end of the previous cumulative quarter. - FY2020-Q2WorsenedAnnual report
「Cash and cash equivalents during the cumulative second quarter decreased by ¥2,046 million from the end of the previous fiscal year to ¥2,270 million.」
Cash and cash equivalents decreased by ¥2,046 million from the end of the previous consolidated fiscal year, leaving a balance of ¥2,270 million. The trend has shifted from an increase in the same period of the previous year to a decrease, and the decline has also widened. - FY2020-Q1Cash balance turned from an increase to a decreaseAnnual report
「This was mainly due to a ¥742 million decrease in cash and deposits resulting from advertising investment and payments for the construction of the drug discovery research center, a ¥434 million increase in notes and accounts receivable resulting from higher sales in the mail-order business, and a ¥480 million increase in property, plant and equipment following completion of construction of the drug discovery research center.」
Cash and deposits decreased by ¥742 million from the end of the previous fiscal year, with advertising investment and payments for construction of the drug discovery research center cited as factors behind the decrease. - FY2019AdvancedAnnual report
「Cash and cash equivalents at the end of the fiscal year increased by ¥1,382 million from the end of the previous fiscal year to ¥4,316 million.」
Cash and cash equivalents increased by ¥1,382 million from the previous fiscal year-end to ¥4,316 million. - FY2019-Q3RestatedAnnual report
「This was mainly due to increases of ¥911 million in cash and deposits and ¥431 million in merchandise and finished goods.」
Cash and deposits increased by ¥911 million from the end of the previous fiscal year to a balance of ¥3,846 million. Although the balance declined from the end of the previous quarter, the increase from the fiscal year-end continued. - FY2019-Q2RestatedAnnual report
「Cash and cash equivalents during the cumulative second quarter increased by ¥1,158 million from the end of the previous fiscal year to ¥4,092 million.」
Cash and cash equivalents continued to increase from the end of the previous fiscal year. - FY2019-Q1Cash balance turned from a decrease to an increaseAnnual report
「This was mainly due to an increase of ¥1,937 million in cash and deposits.」
The previous trend of declining cash from the fiscal year-end reversed, with cash and deposits increasing by ¥1,937 million in the first quarter to a balance of ¥4,872 million. - FY2018-Q3RestatedAnnual report
「Cash and deposits ¥2,710.215 million」
Cash and deposits decreased from ¥2,861.102 million at the end of the previous fiscal year to ¥2,710.215 million, continuing the decline from the fiscal year-end. - FY2018-Q2First statedAnnual report
「Cash and cash equivalents during the cumulative second quarter decreased by ¥584 million from the end of the previous fiscal year to ¥2,290 million.」
The company disclosed that cash and cash equivalents decreased by ¥584 million from the end of the previous fiscal year to ¥2,290 million. Cash flow from operating activities was also an outflow of ¥215 million.